US EditionRevenue Windfall Expected As Dr Reddy’s Lab Gears Up To Launch Generic Obesity Drug - IndiaWest Journal News
Summary by India West
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Revenue Windfall Expected As Dr Reddy’s Lab Gears Up To Launch Generic Obesity Drug - IndiaWest Journal News
India-West News Desk HYDERABAD — Dr Reddy’s Laboratories is gearing up to enter the booming global obesity drug market with a more affordable generic version of Novo Nordisk’s leading weight-loss medication, Wegovy. The company plans to launch the drug in 87 countries next year, focusing initially on emerging markets like India, Canada, Brazil, and Turkey, following the expected expiration of semaglutide patents—the active ingredient in diabetes…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
